Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $470.93 | 30 | 94.2% |
| Education | $28.79 | 2 | 5.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $177.54 | 12 | $0 (2021) |
| Allergan Inc. | $78.19 | 5 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $68.56 | 5 | $0 (2020) |
| Takeda Pharmaceuticals America, Inc. | $43.28 | 2 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.79 | 2 | $0 (2019) |
| Astellas Pharma US Inc | $20.69 | 1 | $0 (2020) |
| Biohaven Pharmaceutical Holding Company Ltd. | $20.60 | 1 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $18.75 | 1 | $0 (2021) |
| ABBVIE INC. | $16.60 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.38 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.60 | 1 | ABBVIE INC. ($16.60) |
| 2022 | $20.60 | 1 | Biohaven Pharmaceutical Holding Company Ltd. ($20.60) |
| 2021 | $39.91 | 2 | PFIZER INC. ($21.16) |
| 2020 | $235.00 | 16 | PFIZER INC. ($142.52) |
| 2019 | $28.76 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($14.90) |
| 2018 | $74.27 | 5 | Allergan Inc. ($62.12) |
| 2017 | $84.58 | 5 | Takeda Pharmaceuticals America, Inc. ($43.28) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: PRIMARY CARE | ||||||
| 12/14/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: PRIMARY CARE | ||||||
| 07/28/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/23/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/16/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/04/2020 | PFIZER INC. | CADUET (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: METABOLIC DISEASE | ||||||
| 10/29/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/08/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/01/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/23/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/01/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/03/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/28/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/30/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/18/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: UROLOGY | ||||||
| 06/15/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/08/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/19/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $3.10 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/07/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Education | In-kind items and services | $14.90 | General |
| Category: RESPIRATORY | ||||||
| 03/13/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/20/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/28/2018 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/22/2018 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 578 | 637 | $149,469 | $59,359 |
| 2022 | 7 | 538 | 573 | $133,311 | $53,328 |
| 2021 | 7 | 547 | 606 | $119,093 | $50,233 |
| 2020 | 8 | 678 | 792 | $136,300 | $55,605 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 270 | 270 | $71,574 | $33,678 | 47.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 172 | 221 | $57,754 | $18,737 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 60 | $11,074 | $3,339 | 30.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 14 | $5,120 | $1,653 | 32.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 35 | 35 | $2,170 | $1,098 | 50.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 24 | 24 | $1,400 | $752.88 | 53.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $377.00 | $100.53 | 26.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 220 | 220 | $57,420 | $28,198 | 49.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 168 | 197 | $53,387 | $16,513 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 68 | 73 | $13,943 | $4,326 | 31.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 15 | 15 | $4,965 | $2,457 | 49.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 42 | 43 | $2,494 | $1,320 | 52.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 13 | $754.00 | $401.34 | 53.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $348.00 | $112.49 | 32.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 181 | 181 | $44,841 | $23,718 | 52.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 163 | 188 | $45,918 | $16,821 | 36.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 105 | 133 | $21,971 | $7,608 | 34.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 52 | 52 | $3,016 | $921.76 | 30.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 19 | 19 | $1,934 | $715.36 | 37.0% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 13 | 19 | $930.00 | $327.42 | 35.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 14 | 14 | $483.00 | $121.31 | 25.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 258 | 258 | $59,340 | $31,167 | 52.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 202 | 271 | $39,295 | $12,184 | 31.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 62 | 69 | $14,835 | $4,998 | 33.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2020 | 20 | 20 | $6,460 | $3,473 | 53.8% |
About Dr. Brian Pickett, MD
Dr. Brian Pickett, MD is a Internal Medicine healthcare provider based in Cranston, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497828628.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Pickett, MD has received a total of $499.72 in payments from pharmaceutical and medical device companies, with $16.60 received in 2024. These payments were reported across 32 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($470.93).
As a Medicare-enrolled provider, Pickett has provided services to 2,341 Medicare beneficiaries, totaling 2,608 services with total Medicare billing of $218,526. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Cranston, RI
- Active Since 11/16/2006
- Last Updated 09/24/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1497828628
Products in Payments
- CHANTIX (Drug) $138.99
- XARELTO (Drug) $68.56
- Trintellix (Drug) $43.28
- NURTEC ODT (Drug) $39.35
- VRAYLAR (Drug) $34.19
- LINZESS (Drug) $27.32
- ELIQUIS (Drug) $21.16
- MYRBETRIQ (Drug) $20.69
- CADUET (Drug) $17.39
- VIBERZI (Drug) $17.02
- BYSTOLIC (Drug) $16.26
- VYVANSE (Drug) $15.38
- SPIRIVA RESPIMAT (Drug) $14.90
- STIOLTO (Drug) $13.89
- DUEXIS (Drug) $11.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cranston
Dr. Gregory Allen, D.o, D.O
Internal Medicine — Payments: $39,714
Dr. Dennis Botelho, Md, MD
Internal Medicine — Payments: $15,096
Dr. Usha Panneerselvam, Md, MD
Internal Medicine — Payments: $11,450
Mr. Stephen Beaupre, Md, MD
Internal Medicine — Payments: $9,665
Dr. James Cardi, M.d, M.D
Internal Medicine — Payments: $6,965
Mrs. Olga Tverskaya, M.d, M.D
Internal Medicine — Payments: $6,262